FDA Approves First New Alzheimer’s Drug in Nearly Two Decades

The Biogen drug was approved after facing controversy over whether it really slows the progression of the memory-robbing disease.

The Wall Street Journal | I+D | Farmacia | Mar, 08/06/2021 - 08:27